PROLYTIX
LIVE

Serial Number

97139287

Owner

Haematologic Technologies, LLC

Attorney

Elizabeth Baumhart

First Use Date

Mar 1, 2022

Filing Date

Nov 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PROLYTIX Trademark

Serial Number: 97139287 • Registration: 7109114

PROLYTIX is a trademark filed by Haematologic Technologies, LLC on November 23, 2021. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Haematologic Technologies, LLC

57 River Road #1021
Essex Junction, VT 05452

Entity Type: 16

Trademark Details

Filing Date

November 23, 2021

Registration Date

July 11, 2023

First Use Anywhere

March 1, 2022

First Use in Commerce

March 1, 2022

Published for Opposition

December 13, 2022

Goods & Services

Protein arrays and reagents for scientific and medical research

Scientific research and development for others in the field of large molecule contract research organizations and blood coagulation; Scientific research and development for others; Design and development of custom blood collection tubes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 6, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 5, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 28, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 27, 2023 AITU
USE AMENDMENT FILED
Feb 7, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 7, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 7, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 25, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 25, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 25, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 25, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 20, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 20, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 20, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2021 NWOS
NEW APPLICATION ENTERED
Nov 26, 2021 NWAP